Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor types, including squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck
• Squamous Cell Carcinoma of the Lung
• Urothelial Cancer

Drugs mentioned

• PF-06940434

Snippet

Sponsor: Pfizer | Conditions: Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma | Phase 1 | Status: TERMINATED